Heart disease is the leading cause of death for women in the United States, yet many physicians wait until cholesterol levels become dangerously high before intervening. This approach can miss the silent cardiovascular changes that often begin during perimenopause, a critical “window of opportunity” for protecting heart health.

Hormonal protection and its loss

Before menopause, estrogen helps clear cholesterol from the bloodstream, keeps blood vessels flexible, supports insulin sensitivity, and moderates inflammation—all essential for a healthy heart. When estrogen levels start to fluctuate in perimenopause and then drop sharply after menopause, these protective mechanisms weaken, even if a standard cholesterol panel still reads within normal limits.

Cholesterol and blood vessels

High‑density lipoprotein (HDL), the “good” cholesterol, transports excess cholesterol to the liver for disposal. Estradiol, the primary form of estrogen, regulates both the amount of HDL and its effectiveness. As estradiol declines, HDL particles can become smaller and less efficient, even when HDL levels appear normal on a lab report.

At the same time, low‑density lipoprotein (LDL) and apolipoprotein B (ApoB)—markers of plaque‑forming particles—rise most rapidly in the year before and after menopause. The result is more “bad” cholesterol and fewer effective “good” particles to clear it. Blood vessels may also become stiffer, creating a more favorable environment for plaque buildup. A study of over 52,000 women linked estrogen loss during menopause with increased arterial stiffness.

Abdominal fat and blood sugar

Estrogen normally directs fat storage to the hips and thighs. As estrogen declines, fat tends to accumulate around the midsection, where it poses a greater risk to the heart. The 2021 Study of Women’s Health Across the Nation (SWAN) found that visceral fat—deeply embedded fat surrounding internal organs—rises from roughly 5%–8% of total body fat before menopause to 15%–20% afterward. This increase is associated with greater arterial plaque and a higher risk of stroke.

Estrogen also aids insulin sensitivity. Lower estrogen can lead to increased insulin resistance, raising the likelihood of high blood sugar, elevated blood pressure, and cardiovascular disease.

Blood pressure, inflammation, and clotting

Estrogen’s anti‑inflammatory properties help keep blood vessels supple and blood pressure stable. When estrogen levels fall, both inflammation and blood pressure may rise, thickening arteries and encouraging plaque formation. Additionally, estrogen helps regulate platelets; its decline can make the clotting system more reactive. A clot forming on arterial plaque can block blood flow to the heart or brain, causing a heart attack or stroke. These changes help explain why stroke rates double for women between their late forties and early sixties.

Screening beyond the standard cholesterol panel

Because estrogen fluctuations can mask underlying risk, women should discuss additional testing with their physicians. Measuring estrogen itself does not directly indicate heart risk, but evaluating arterial inflammation, metabolic health, liver function, and comprehensive lipid profiles (including ApoB) can provide a clearer picture.

Hormone replacement therapy (HRT) as a tool

For many women, appropriately timed hormone replacement therapy can restore estrogen levels and reduce the factors driving heart disease. The cardiovascular benefit is most pronounced when HRT is started before age 60 or within ten years of menopause. In the large Women’s Health Initiative study, women aged 50–59 who received estrogen‑only HRT experienced a 40% lower risk of heart attack compared with those on placebo. After age 60, the risk‑benefit balance shifts, requiring individualized assessment.

The formulation of HRT matters. Oral estrogen passes through the liver and may raise triglycerides and clotting factors in some women, while transdermal estrogen (patch, gel, or cream) bypasses the liver and often offers a more favorable clotting profile. Whether a woman needs estrogen alone or combined with progesterone depends on her health history and whether she has a uterus.

Lifestyle measures to support heart health

Hormones are only one piece of the puzzle. Strength training, regular aerobic activity, adequate sleep, and a balanced diet all influence ApoB, blood pressure, and insulin resistance—the same markers that drive cardiovascular risk. Women should work with clinicians familiar with their personal and family health history to create a comprehensive plan that includes both medical and lifestyle strategies.

By recognizing perimenopause as a pivotal period for cardiovascular health and taking proactive steps—whether through targeted testing, thoughtful hormone therapy, or lifestyle adjustments—women can better safeguard their hearts during and after the transition to menopause.

Original reporting: El Paso News (HLL/CB) — read the source article.